Evolving Therapies for Geographic Atrophy
Available from: 1/05/2025 ()
Where to publish: https://lms.optometry.org.au/course/view.php?id=875
Provider: Mivision
Activity Outline
Over recent years, investigations into the genetics of age-related macular degeneration (AMD)– and specifically geographic atrophy (GA) – have allowed for deeper understandings of the disease. This article considers the implications of evolving therapies on the treatment of this sight-threatening condition.
Learning Objectives
- Understand the characteristics of GA and its natural history
- Be aware of the imaging modalities used to observe geographic atrophy onset and progression
- Understand the genetic and systemic risk factors of GA
- Be aware of existing and emerging therapeutic therapies
Max CPD hours awarded: 1.25
Session Information
| Name |
|---|
| Evolving Therapies for Geographic Atrophy |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |